Your session is about to expire
← Back to Search
Resiliency & Burnout Interventions for Behavioral Health Staff
N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
Study Summary
This trial will compare two interventions to reduce burnout, improve resiliency, and reduce turnover in group homes for adults with serious mental illness and/or developmental/intellectual disabilities. Researchers will measure the effectiveness of each intervention.
Who is the study for?
This trial is for permanent-salary staff at certain group homes for adults with serious mental illness or intellectual and developmental disabilities. It's not open to temporary or per diem workers, nor staff at non-participating group homes.Check my eligibility
What is being tested?
The study compares two programs: Integrated Resiliency Training and Task Sharing (IRTTS) versus Workplace Improvement Learning Collaborative (WILC). It looks at which is better for improving staff resiliency, stress management, health behaviors, job retention, safety in the home, and reducing burnout.See study design
What are the potential side effects?
Since this trial involves training sessions and collaborative work rather than medical treatments, traditional side effects are not expected. However, participants may experience changes in stress levels or emotional states due to the nature of the interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Resilience (12-month follow-up)
Resilience (3-month follow-up)
Resilience (baseline)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Workplace Improvement Learning CollaborativeExperimental Treatment1 Intervention
A workplace improvement learning collaborative implemented at the organization level (mesosystem).
Group II: Integrated Resiliency Training and Task SharingExperimental Treatment2 Interventions
A multi-component intervention combining resiliency training and task sharing implemented at the site-level (microsystem).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resiliency Training
2014
N/A
~5520
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,197,455 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,995,648 Total Patients Enrolled
VinfenUNKNOWN
2 Previous Clinical Trials
1,205 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Integrated Resiliency Training and Task Sharing
- Group 2: Workplace Improvement Learning Collaborative
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research project enrolling participants at present?
"According to the information found on clinicaltrials.gov, this experiment is not currently recruiting participants. It was initially posted in March 2023 and most recently updated April 6th of that year. Although there are no openings for this trial at present, 1737 other trials are open for enrollment."
Answered by AI
Who else is applying?
What state do they live in?
Massachusetts
What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Share this study with friends
Copy Link
Messenger